ID
31372
Description
Study ID: 104507 Clinical Study ID: BEX104507 Study Title: Phase II Study of Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphoma Patients who have Previously Received Rituximab Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996593 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin
Keywords
Versions (3)
- 7/23/18 7/23/18 -
- 8/18/18 8/18/18 -
- 3/15/21 3/15/21 - Dr. rer. medic Philipp Neuhaus
Copyright Holder
GlaxoSmithKline
Uploaded on
August 18, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphomas NCT00996593
Concomitant Medications and Transfusions and Adverse Experiences
- StudyEvent: ODM
Description
Concomitant Medications and Transfusions
Alias
- UMLS CUI-1
- C4284232
- UMLS CUI-2
- C0521115
- UMLS CUI-3
- C1879316
- UMLS CUI-4
- C0521115
Description
Drug or Blood Product
Data type
text
Alias
- UMLS CUI [1]
- C0013227
- UMLS CUI [2]
- C0456388
Description
Drug or Blood Product Dose
Data type
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [2,1]
- C0456388
- UMLS CUI [2,2]
- C0178602
Description
Drug or Blood Product Dose Unit
Data type
text
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0178602
- UMLS CUI [1,3]
- C0439148
- UMLS CUI [2,1]
- C0456388
- UMLS CUI [2,2]
- C0178602
- UMLS CUI [2,3]
- C0439148
Description
Route of drug administration
Data type
text
Alias
- UMLS CUI [1]
- C0013153
Description
Medication frequency | Transfusion (procedure); Frequencies (time pattern)
Data type
text
Alias
- UMLS CUI [1]
- C3476109
- UMLS CUI [2,1]
- C1879316
- UMLS CUI [2,2]
- C0439603
Description
Date treatment started
Data type
date
Alias
- UMLS CUI [1]
- C1531783
Description
Date treatment stopped
Data type
date
Alias
- UMLS CUI [1]
- C1531784
Description
continuing therapy
Data type
text
Alias
- UMLS CUI [1]
- C1553904
Similar models
Concomitant Medications and Transfusions and Adverse Experiences
- StudyEvent: ODM
C1704732 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,2])
C0521115 (UMLS CUI-2)
C1879316 (UMLS CUI-3)
C0521115 (UMLS CUI-4)
C0456388 (UMLS CUI [2])
C0178602 (UMLS CUI [1,2])
C0456388 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0178602 (UMLS CUI [1,2])
C0439148 (UMLS CUI [1,3])
C0456388 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0439148 (UMLS CUI [2,3])
C1879316 (UMLS CUI [2,1])
C0439603 (UMLS CUI [2,2])